Nottingham
United Kingdom
University of Nottingham - Ex Vivo Cancer Pharmacology Centre of Excellence
esophageal adenocarcinoma, cancer associated fibroblasts, phosphodiesterase type 5 inhibitors, chemotherapy, preclinical models